Yi Larson
CIK 1785987 · Chief Financial Officer · last filed 2025-06-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
17
Lifetime Open-Market Net
-$3.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OLMA | Director | — | $9.87 | — | $0 | 7 | 2025-06-13 |
| RayzeBio, Inc. (RYZB) Delisted | Director | — | $62.49 | — | $0 | 1 | 2024-02-27 |
| LianBio (LIAN) Delisted | Chief Financial Officer | 325,901 | $0.32 | $104.0K | $0 | 4 | 2023-03-31 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | EVP & Chief Financial Officer | 7,321 | $76.01 | $556.5K | -$3.70M | 5 | 2021-02-10 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-10 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2021-04-06 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2021-02-10 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Grant (A) | +4,617 | $0 | EDGAR |
| 2021-02-02 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Mixed | — | -$2.18M | EDGAR |
| 2020-01-08 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-11 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Buy (P) | +2,222 | $100.0K | EDGAR |
| 2019-08-27 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.